首页|基于网络药理学和分子对接技术探讨石菖蒲-川芎治疗阿尔茨海默病的潜在机制

基于网络药理学和分子对接技术探讨石菖蒲-川芎治疗阿尔茨海默病的潜在机制

扫码查看
目的 基于网络药理学和分子对接技术探索中药药对石菖蒲-川芎在治疗阿尔茨海默病(AD)的有效成分和作用靶点.方法 采用TCMSP平台对石菖蒲和川芎的有效成分及相关靶点进行筛选.从GEO数据库中获得AD的差异表达基因,并通过Perl5.30.2.1软件获得疾病和药物的交叉差异基因.对交叉差异基因进行蛋白质相互作用(PPI)构建、GO功能富集分析、KEGG通路富集分析.使用AutoDockTools1.5.6软件将主要活性成分与核心靶点进行分子对接验证.结果 共筛选出14个活性成分,其中山柰酚、β-细辛醚、8-异戊烯基-山柰酚、(1R,3aS,4R,6aS)-1,4-双(3,4-二甲氧基苯基)-1,3,3a,4,6,6a-六氢呋喃[4,3-c]呋喃、杨梅酮、香兰素、川芎哚7个活性成分被确定为与大多数靶基因相关的活性成分.获得交叉差异基因21个.通过拓扑分析,发现强相关蛋白18个,其中10个靶点为预测的核心靶点.细胞组分富集67个,分子功能富集73个,生物过程富集465个;KEGG共富集信号通路31条.分子对接结果表明,7个关键成分具有与目的基因HSP90AA1、ADRA2C、GABRA1、CHRM3具有较好的亲和力.结论 石菖蒲-川芎主要活性成分可能通过神经活性配体受体相互作用、流体剪切应力和动脉粥样硬化、钙信号通路等信号通路,作用于HSP90AA1、ADRA2C、GABRA1、CHRM3等靶点,从而发挥治疗AD的作用.
Exploration on the Potential Mechanism of Acori Tatarinowii Rhizoma-Chuanxiaong Rhizoma in the Treatment of Alzheimer's Disease Based on Network Pharmacology and Molecular Docking Technique
Objective To explore the active components and action targets of Acori Tatarinowii Rhizoma-Chuanxiaong Rhizoma in the treatment of Alzheimer's disease(AD)based on network pharmacology and molecular docking technology.Methods The TCMSP platform was used to screen the active components and related targets of Acori Tatarinowii Rhizoma-Chuanxiaong Rhizoma.Differentially expressed genes for AD were obtained from the GEO database.Cross-disparate genes for diseases and drugs were obtained by Perl software.The cross-disparate genes were analyzed by protein interaction(PPI)construction,GO and KEGG enrichment.AutoDockTools1.5.6 software to perform molecular docking validation between the main active components and the core targets.Results A total of 14 active components were screened.Seven of the active components(kaempferol,β-fine-octyl ether,8-isopentenyl-kaempferol,(1R,3aS,4R,6aS)-1,4-bis(3,4-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[4,3-c]furan,yangmei ketone,vanillin,and chuanxiongxiongdiao)were identified as the most relevant active ingredients.21 cross-differential genes were obtained.By topological analysis,18 strongly related proteins were identified,of which 10 targets were predicted core targets.A total of 67 cellular components,73 molecular functions and 465 biological processes were enriched;31 signaling pathways were enriched by KEGG.The molecular docking results showed that the key components of 7 had the affinity with the target genes HSP90AA1,ADRA2C,GABRA1,and CHRM3 with higher number.Conclusion The key active components of Acori Tatarinowii Rhizoma-Chuanxiaong Rhizoma may exert therapeutic effects on AD through signaling pathways such as neuroactive ligand-receptor interactions,fluid shear stress and atherosclerosis,and calcium signaling pathway,acting on the targets of HSP90AA1,ADRA2C,GABRA1,and CHRM3.

Acori Tatarinowii RhizomaChuanxiaong RhizomaAlzheimer's diseasenetwork pharmacology

曹楠、叶智裕、莫彬艳、王宁、陈洪达

展开 >

中山大学附属第七医院,广东 深圳 518107

石菖蒲 川芎 阿尔茨海默病 网络药理学

广东省中医药局科研项目

20211098

2024

中国中医药图书情报杂志
中国中医科学院中医药信息研究所

中国中医药图书情报杂志

影响因子:0.556
ISSN:2095-5707
年,卷(期):2024.48(5)
  • 6